Skip to Content
Morningstar

Sartorius Stedim Biotech SA DIM

Morningstar Rating
Unlock
Stock XPAR Rating as of
€182.65 −0.50 (0.27%)
View Full Chart
As of Delayed Price Closed
Unlock our analysis with Morningstar Investor
Start Free Trial

Company Report

View Archive

Sartorius Stedim Experiencing Tough 2023 Reset, but Long-Term Story Intact

Jay Lee

Sartorius Stedim Biotech, the bioprocess subsidiary of Sartorius AG, is a leading provider of single-use biopharmaceutical fermentation and fluid management solutions. Sartorius performs consultations and custom installations of biomanufacturing systems for its drugmaker clients, which include bioreactors, filtration and purification systems, and cell analysis systems. This equipment has high disposable consumable requirements, including single-use bioreactor bags, filters, tubes, and containers. The company’s proven expertise in single-use technology, or SUT, and the regulation-validated nature of biomanufacturing gives Sartorius an attractive razor-and-blades model and supports a wide economic moat.

Read Full Report

Price vs Fair Value

View History
DIM is trading within a range we consider fairly valued.
Price
€183.15
Fair Value
€682.00
Uncertainty
High
1-Star Price
€466.00
5-Star Price
€191.00
Economic Moat
Yslhx
Capital Allocation
Ytsyvbskt

Bulls Say, Bears Say

Bulls

Sartorius has limited customer concentration risk, and smaller customers account for a majority of revenue.

Bears

Sartorius risks overpaying for acquisitions to achieve somewhat arbitrary growth targets, such as its goal of EUR 4 billion of sales by 2025.

Show More
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if DIM is a good fit for your portfolio.
Get 7 Days Free

News

View All

Trading Information

Previous Close Price
€183.15
Day Range
€181.15–183.50
52-Week Range
€160.55–287.80
Bid/Ask
€182.50 / €183.50
Market Cap
€17.77 Bil
Volume/Avg
167,808 / 73,104

Key Statistics

Price/Earnings (Normalized)
42.66
Price/Sales
6.08
Dividend Yield (Trailing)
0.38%
Dividend Yield (Forward)
0.38%
Total Yield
0.38%

Company Profile

Sartorius Stedim Biotech, or SSB, is a leading provider of bioprocessing solutions. Its sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs, and has a focus on single-use technology, or SUT. It is a subsidiary of Sartorius AG, which has a 74% ownership and 85% voting control. The business is geographically diverse.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Large Growth
Total Number of Employees
10,662
Website
https://www.sartorius.com

Competitors

Valuation

View More
Metric
DIM
A
WAT
Price/Earnings (Normalized)
 42.6624.4226.18
Price/Book Value
 6.406.1214.52
Price/Sales
 6.085.836.27
Price/Cash Flow
 38.4520.5522.11
Price/Earnings
DIM
A
WAT

Financial Strength

Metric
DIM
A
WAT
Quick Ratio
 0.491.881.39
Current Ratio
 1.512.682.22
Interest Coverage
 4.3814.838.28
Quick Ratio
DIM
A
WAT

Profitability

Metric
DIM
A
WAT
Return on Assets (Normalized)
 6.21%14.63%17.19%
Return on Equity (Normalized)
 15.23%27.31%88.59%
Return on Invested Capital (Normalized)
 9.77%18.86%25.75%
Return on Assets
DIM
A
WAT
See how this stock stacks up to its competitors with Morningstar Investor
Start Free Trial

Medical Instruments & Supplies Industry Comparables

Screen in Investor
Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ISRG
Intuitive Surgical IncTbfyddfxKtyw$142.6 Bil
BDX
Becton Dickinson & CoPkgtlwmnQtslf$67.0 Bil
ALC
Alcon IncNjcjjwlwScqzh$43.3 Bil
RMD
ResMed IncWnfszdlfysHygfgp$30.8 Bil
CLPBY
Coloplast A/S ADRSqksskcwkBdcm$27.0 Bil
WST
West Pharmaceutical Services IncZmvvmskwbDbckp$24.1 Bil
COO
The Cooper Companies IncMjbdgtpSrvjjnq$17.9 Bil
BAX
Baxter International IncVxbhshrhBkyhdc$17.0 Bil
HOLX
Hologic IncBmjhckygYqryxm$16.9 Bil
ATR
AptarGroup IncBvncfdtllYrcmcnw$9.6 Bil

Sponsor Center